Related Experiment Videos
[Argentine consensus on sleep-related respiratory disorders]
1Sección Insuficiencia Respiratoria y Trastornos del Sueño de la Asociación Argentina de Medicina Respiratoria y Asociación Argentina de Medicina del Sueño, Buenos Aires. hsala@janssen.com.ar
Medicina
|July 28, 2001
Summary
Experts established common criteria for diagnosing and managing sleep disorders like sleep apnea/hypopnea syndrome (SA/HS). Nasal CPAP is the primary treatment for SA/HS, with standardized diagnostic and treatment protocols recommended.
Area of Science:
- Sleep Medicine
- Respiratory Medicine
- Public Health
Background:
- Growing medical interest in sleep disorders necessitates standardized diagnostic and management criteria.
- Sleep apnea/hypopnea syndrome (SA/HS) affects 2-4% of adults, with higher prevalence in the elderly, presenting risks like cardiovascular disease and accidents.
- Excessive daytime somnolence (EDS) is a key symptom, also associated with increased upper airways resistance syndrome.
Framework:
- A standardized questionnaire was developed for evaluating patients with respiratory sleep disorders (RSD).
- Polysomnography is the gold standard for diagnosing RSD, with standardized minimal requirements for split-night and screening studies.
- Specific indications for diagnostic studies were summarized.
Implementation:
- Medical treatment of obesity in relation to RSD was analyzed.
- Nasal continuous positive airways pressure (CPAP) is the first-line treatment for SA/HS, with standardized titration protocols.
- Oral appliances and uvulopalatopharyngoplasty are considered for specific patient groups based on diagnostic findings.
Implications:
- Standardized management includes periodic clinical control and using the Epworth test for EDS assessment.
- Time-controlled devices are recommended for evaluating CPAP compliance.
- Established criteria aim to improve diagnosis, treatment, and management of prevalent sleep disorders.